Injectable Gel with 0.3% Lidocaine

Similar documents
RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds

Table of Contents. Injectable Gel with 0.3% Lidocaine

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner.

Caution: Federal Law restricts this device to sale by or on the order of a physician or licensed practitioner.

WHAT YOU SHOULD KNOW ABOUT RoACTEMRA

SCULPTRA Aesthetic (First Treatment Session: N = 116) Cosmoplast (First Treatment Session: N = 117) Severity of Adverse Event a Moderate n.

YOUR BEST DAYS START WITH BETTER PROTECTION FROM LOWS. *,1,2

INFORMATION FOR YOU AND YOUR FAMILY. Melody Transcatheter Pulmonary Valve Therapy

Information Following Treatment for Patients with Early Breast Cancer. Bradford Teaching Hospitals. NHS Foundation Trust

A PATIENT S GUIDE TO PLASMA EXCHANGE

OPIOID OVERDOSE RELATED EMERGENCY DEPARTMENT VISITS AT PROVIDENCE EVERETT

Primary: To assess the change on the subject s quality of life between diagnosis and the first 3 months of treatment.

There s. more. to you THAT S WHY THERE S MORE TO GAMUNEX-C. *CIDP=Chronic inflammatory demyelinating polyneuropathy.

Sexuality and chronic kidney disease

Meningococcal B Prevention Tools for Your Practice

A Patient s Guide to Aesthetic Treatments

Hospital Measures. Region 1

Modified Early Warning Score Effect in the ICU Patient Population

Click to Edit Master Title

Hospital Measures. Region 3. Twin Cities Metro: Anoka, Carver, Dakota, Hennepin, Ramsey, Scott, Washington

There s. to them THAT S WHY THERE S MORE TO GAMUNEX-C

Hospital Measures. Region 2

INJECTABLE IMPLANT INSTRUCTIONS FOR USE

PATIENT INFORMATION BOOKLET. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods

A guide to immunisations up to 13 months of age

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better:

Lidocaine PATIENT INFORMATION GUIDE

DESCRIPTION 1. Composition

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Stacy Norman, D.D.S. William A. Stellenwerf, M.S., D.D.S., P.C Timber Shadows Dr., Bldg. A Kingwood, Texas (281)

Hospital Measures. Region 4

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team.

Certify your stroke care program. Tell your community you re ready when needed.

PATIENT REGISTRATION

Preparing for Colon or Rectal Surgery

New guidance from the Royal College of Radiologists Standards for Intravascular Contrast administration to adult patients 9, 11, 12

Disclosures. Pain Management in the Optometric Practice. Optometric indications. Optometric indications. Before treatment 4/18/16

Measures of Spread: Standard Deviation

More than skin deep. The medical uses of BOTOX

prescription drug Approval No. solution Attached dissolving (Content per kit) Flomoxef sodium 1 g (potency) Sodium chloride 50 mg

stroke patient handbook

Systemic and Novel Management of Alopecia Areata in Children. Alopecia Areata: Prognosis. Alopecia Areata. Alopecia Areata: Pathogenesis

MEDICAL HOME: Inside: Feeling Blue about the Holidays? Disordered Eating

STATISTICAL ANALYSIS & ASTHMATIC PATIENTS IN SULAIMANIYAH GOVERNORATE IN THE TUBER-CLOSES CENTER

Raising Healthy Kids: Colostrum Management and Prevention of Failure of Passive Transfer

Basic Requirements. of meeting cow herd production and profitability goals for the beef cattle enterprise.

Hypertension in patients with diabetes is a well recognized

Intrathecal pumps for pain therapy. Lennart Stieglitz

Sample. Do not reproduce.

Management of Preschool Recurrent Wheezing and Asthma: A Phenotype-Based Approach

Opinion 22 January 2014

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES*

Report on sexual activity and contraceptive methods for female. June 2014

APPROVAL REQUIRED. By approving this proof you are confirming that the contact information is correct.

SPONDYLODISCITIS KEY POINTS

MICHELANGELO: OASIS 5 Women s Substudy

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients

Mechanism of Action: The Importance of Liver THR-β in NASH

A COMBINATION OF ANALGESIC AND IN POSTOPERATIVE PAIN

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Statistics 11 Lecture 18 Sampling Distributions (Chapter 6-2, 6-3) 1. Definitions again

COMPARISON OF A NEW MICROCRYSTALLINE

5/7/2014. Standard Error. The Sampling Distribution of the Sample Mean. Example: How Much Do Mean Sales Vary From Week to Week?

Research Article. The efficacy of continuous versus intermittent celecoxib treatment in osteoarthritis patients aged <60 and 60 years

Quick Reference to Transthoracic Echo Screening

Esteemed Faculty. Michael A. LeNoir MD, FAAP, FAAAI. Jointly sponsored by AKH Inc., Advancing Knowledge in Healthcare and Not One More Life, Inc.

Objectives. Sampling Distributions. Overview. Learning Objectives. Statistical Inference. Distribution of Sample Mean. Central Limit Theorem

Clinical Research The details of the studies undertaken year wise along with the outcomes is given below: SNo Name of Project

Pilot and Exploratory Project Support Grant

Years K-2. Information. Introduction. Key understandings

The Skeletal System: Bone Tissue Chapter 6. Copyright 2009, John Wiley & Sons, Inc.

WHAT YOU NEED TO KNOW ABOUT CANCER

VAPREVENT SYSTEM. Evidence-based innovation in oral care

n Need for surgery recently challenged n increasing adult literature n emerging pediatric evidence n Parents may want to avoid operation

Disclosure. Update in Pediatric Asthma 7/5/16. Topics. California Society for Respiratory Care Indian Wells, CA June 7, 2016

Safety concerns regarding inhaled adrenergic. Long-acting b-agonists: a review of formoterol safety data from asthma clinical trials

HELP RESTORE A MORE YOUTHFUL LOOK

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager

One-week Oral Challenge with Penicillin in Diagnosis of Penicillin Allergy

INTERNATIONAL STUDENT TIMETABLE SYDNEY CAMPUS

CURRENT ALCOHOL USE IS ASSOCIATED WITH A REDUCED RISK OF HOT FLASHES IN MIDLIFE WOMEN

Chapter 25 Fluid, electrolyte, and acid-base homeostasis

1.#GLOSSARY#.#2 2.#PRODUCT#DESCRIPTION# #ABOUT#BELLAFILL #.#4 3.#INDICATION/INTENDED#USE#.#4 4.#SAFETY#.#4 5.#RISKS#.#6 6.#7 7.#ABOUT#THE#PROCEDURE#

Skeletal System. Bones Protect. Bones. Bones Store. Bones Move SECTION 2: THE SKELETAL SYSTEM 4/4/16

How a Written Back-Up Plan Saves Money and Lives. Jill Emerick, MD

Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus

Retention in HIV care among a commercially insured population,

Teacher Manual Module 3: Let s eat healthy

Patient Enrollment Form

Review for Chapter 9

Psychophysiological Alterations in Posttraumatic Stress Disorder

You Take My Breath Away: Management of Asthma in Children. David Seal, Pharm.D., BCACP, MS March 10, 2019

Valve Aortic Accessories Trifecta Valve Sizer Set Handles Global Headquarters Cardiovascular Division St. Jude Medical Coordination Center BVBA

Chronic / Sublethal Bioassays

Estimation and Confidence Intervals

Working Together to Improve Patient Safety...Innovations in Fall Prevention. My Hope: My Goals. Challenges

Specialties. SFunctional Acids

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University.

Simple intervention to improve detection of hepatitis B and hepatitis C in general practice

Transcription:

Patiet Brochure

Table of Cotets Frequetly Asked Questios 4 Safety 6 Troubleshootig 11 Admiistratio 12 Ijectable Gel with.3% Lidocaie Post Marketig Surveillace 13 Post-treatmet Checklist 14 User Assistace Iformatio 16 2 3

Frequetly Asked Questios Q What is Perlae -L? A Perlae -L is a crystal clear ijectable gel composed of hyaluroic acid, a atural substace that already exists i the body. Perlae -L is oaimal-based ad free from aimal protei. Allergy pretestig is ot ecessary. Perlae -L cotais.3% lidocaie. The lidocaie i Perlae -L has bee added to reduce the discomfort associated with the treatmet. Q How does Perlae -L work? A Perlae -L is ijected ito the ski with a ultrafie eedle to plump the ski to smooth away wrikles ad folds such as the lies from your ose to the corers of your mouth (asolabial folds) Q How log does Perlae -L last? A Perlae -L effects geerally last about six moths ad gradually disappears from the body. Q Has Perlae -L bee studied? A A cliical study was coducted with Perlae -L to evaluate the pai reducig effect up to 6 miutes after ijectio. This study erolled 6 patiets with moderate to severe asolabial fold wrikles. The study icluded 56 female patiets ad 4 male; 39 were White, 16 were Hispaic or Latio, ad 5 were Africa-America. I this study 95% of patiets experieced less pai after ijectio of Perlae -L tha with Perlae aloe. Please see the below table for additioal iformatio. Timepoit Number of patiets with assessmets Number of patiets with pai reductio No. % After Ijectio 6 57 95. 15 Miutes 6 34 56.7 3 Miutes 6 24 4. 45 Miutes 6 11 18.3 6 Miutes 6 5 8.3 I additio to evaluatig the pai reducig effects, the study assessed patiet satisfactio with Perlae -L treatmet. All 6 subjects were asked to rate the level of improvemet see i their asolabial folds after ijectio with Perlae -L. At day fourtee after ijectio 95.% saw some improvemet (Improved, Much Improved, ad Very Much Improved). See below table for additioal details. Perlae-L Category % Very Much Improved (4) 24 4. Much Improved (3) 18 3. Improved (2) 15 25. No Chage (1) 3 5. Worse (). 4 5

Safety Q Who should ot use Perlae -L (Cotraidicatios)? A Safety has ot bee established for use i people who are: Pregat Breast feedig Wishig to be pregat Uder 18 years or over 65 years Highly allergic (for example: gram positive bacteria) Proe to bleedig disorders Q What are some warigs to cosider? A The use of Perlae -L at sites with ski sores, pimples, rashes, hives, cysts, or ifectios should be postpoed util healig is complete. Use of Perlae -L i these istaces could delay healig or make your ski problems worse. You may experiece ski discoloratio (bruisig), swellig, redess, tederess, pai, itchig, or small lumps i the area where you are ijected. If ay of these evets occur, the majority usually last less tha seve days. If ay symptom lasts loger tha two weeks, call the doctor who admiistered the Perlae -L ijectio. Iflammatory papules (red or swolle small bumps) may rarely occur. You may eed atibiotics to treat them. Q What are some potetial risks you may ecouter? A As with all procedures like this, the ijectio of Perlae -L carries a risk of ifectio ad formatio of scar tissue. The safety ad effectiveess of Perlae -L has ot bee established i the treatmet of lips, durig pregacy, i ursig mothers, ad i patiets uder 18 or over 65 years of age. Perlae -L use i ursig could harm you or the ursig child. The use of Perlae -L i Africa-America patiets ca result i hyperpigmetatio (darkeig of ski color), which may take several weeks to correct. If you have previously had facial cold sores, a ijectio ca cause them to come back. The safety of Perlae -L used with other ski therapies such as laser, mechaical or chemical peelig, ad hair removal has ot bee established. The use of Perlae -L with these ski therapies may lead to other side effects such as iflammatio. You should avoid exposig the area(s) treated with Perlae -L to excessive su or UV lamps, ad extreme heat ad cold util ay redess or swellig has disappeared. 6 7

Cliical voluteers keepig diaries reported the followig short-lived evets: Perlae -L was evaluated i a cliical study of 6 patiets. The below table shows what patiets reported each day after ijectio of Perlae -L i the diary they kept. The most commo evets were: pai, swellig, redess, tederess, bruisig, itchig ad other. The reportig of these evets decreased over time ad by day 14 most evets had resolved. Duratio of Adverse Evets after Iitial Treatmet, Patiet Diary Bruisig Redess Swellig Pai Tederess Itchig Other Perlae-L Total patiets reportig symptoms 36 (6.%) 34 (56.7%) 42 (7.%) 28 (46.7%) 5 (83.3%) 16 (26.7%) 3 (5.%) 1 6 (16.7%) 9 (26.5%) 4 (9.5%) 17 (6.7%) 6 (12.%) 5 (31.3%) Perlae-L Patiets Number of days 2 7 27 (75.%) 24 (7.6%) 33 (78.6%) 11 (39.3%) 4 (8.%) 1 (62.5%) 3 (1.%) 8 13 3 (8.3%) 4 (9.5%) 4 (8.%) 1 (6.3%) 14 1 (2.9%) 1 (2.4%) Q What should patiets do prior to treatmet? A Perlae -L requires o pretestig, but you should take a few precautios before beig treated. Avoid usig St. Joh s Wort, high doses of Vitami E supplemets, aspiri, ad other o-steroidal ati-iflammatory medicatios, such as ibuprofe prior to treatmet, because these may icrease bruisig or bleedig at the ijectio site. Also, if you have previously suffered from facial cold sores, discuss this with your physicia. He or she may cosider prescribig a medicatio to miimize recurreces. Q Why add Lidocaie to Perlae? A Lidocaie was added to Perlae to reduce pai ad discomfort durig ad after ijectio. I a cliical study, 6 patiets received Perlae o oe side of the face ad Perlae -L o the other side of the face. Perlae -L had a effect o reducig pai. At the time of ijectio, patiets rated their pai about 47 o a scale of to 1 for the side of the face treated with Perlae. I compariso, patiets rated their pai about 15 o the same scale for the side of the face treated with Perlae -L. Patiets reported less pai o the side of the face treated with Perlae -L up to 6 miutes after treatmet. Q What are the major side effects? A Rarely, the doctor may iadvertetly iject the product ito a blood vessel, which ca cause ijury to the blood supply ad damage to the ski. Rarely, a few people have developed ifectios that must be treated with atibiotics or other treatmet. Ifectio may be hard to treat, but will geerally go away whe the gel is absorbed. 8 9

Q Do the ijectios hurt? A Perlae -L is ijected directly ito the ski i tiy amouts by a ultrafie eedle. To help maximize your comfort, you should discuss the use of umbig medicies with your doctor before treatmet. Q How much does Perlae -L treatmet cost? A Perlae -L is a customized procedure based o your specific eeds, so the cost will vary from patiet to patiet. I geeral, the cost of Perlae -L is similar to the cost of similar procedures. Please ask your doctor to give you a estimate of the cost. Troubleshootig Q What should I call my doctor about after the treatmet? A Most side effects like bruisig, swellig, pai, tederess, redess, ad itchig will usually go away withi a week. Call your doctor if you have persistet problems beyod 14 days. Blisters or ski sores that recur may sigal the presece of a herpes ifectio that must be treated. You ca develop a ifectio that should be treated with atibiotics. If you experiece redess, tederess, ad pai that does ot go away you should call your doctor. 1 11

Admiistratio Q What is the dose of Perlae -L? A The amout used depeds o your face ad what you would like to have treated. The average patiet who has all of the severe wrikles aroud the mouth corrected will use less tha half a tablespoo. Post Marketig Surveillace: Q: Have there bee adverse evets reported through post market surveillace? A: Serious adverse evets have bee rarely reported. The oly Serious Adverse Evet occurrig i a frequecy of 5 or greater was hypersesitivity (abormal sesitivity). Hypersesitivity reactios occurred withi 1 to 2 days of implatatio ad up to 3 weeks. Reported symptoms icluded swellig, itchig o chest ad back, puffy, burig, watery, ad itchy eyes, ad shortess of breath. Treatmets used icluded steroids, diphehydramie, uspecified itraveous medicatio, oxyge ad various creams. Most hypersesitivity evets have resolved withi 1 to 14 days with or without treatmet. Adverse evets that have occurred at the ijectio sites iclude: discoloratio, bruisig, swellig, lumps/bumps, redess, pai, scarrig, umbess/tiglig, ad ecrosis (death of tissue), ad ischemia (low blood supply due to blockage of a blood vessel). Additioal evets iclude: bacterial ifectios, vasovagal reactios (faitig), herpetic eruptios, broke capillaries (dilated small blood vessels), ad iflammatory reactios (swellig, redess, tederess, hardess ad aceform papules). 12 13

Is there a post-treatmet checklist to follow after a Perlae -L treatmet? Please observe the followig after treatmet with Perlae -L: Cold compresses (a cloth dipped i cold water, wrug out, ad applied to the ijected area) may be used immediately after treatmet to reduce swellig. Avoid touchig the treated area withi six hours followig treatmet so you do ot accidetally ijure your ski while the area is umb. After that, the area ca be getly washed with soap ad water. Util there is o redess or swellig, avoid exposure of the treated area to itese heat (su lamp or su bathig). If you have previously suffered from facial cold sores, there is a risk that the eedle puctures could cotribute to aother occurrece. Speak to your physicia about medicie to prevet this from happeig agai. Avoid takig aspiri, o-steroidal atiiflammatory medicatios, St. Joh s Wort, ad high doses of Vitami E supplemets for oe week after treatmet. These agets may icrease bruisig ad bleedig at the ijectio site. 14 15

User Assistace Iformatio Your questios about Perlae -L ca be persoally aswered by cotactig the Medicis toll-free call ceter, 24 hours per day, 7 days per week. 1-8-9-6389 Perlae is a registered trademark of HA North America Sales AB. 21 Medicis Aesthetics Ic. 131288 Revised 1/21